Substrates for peptidase C33.001: equine arteritis virus Nsp2-type cysteine peptidase
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equine arterivirus ORF1ab polyprotein | P19811 | 1-3175 | peptide-Gly831+Gly-peptide | P | CS | Arg | Leu | Ile | Gly | Gly | Trp | Ile | Tyr | Ziebuhr et al., 2000 | ||
| Lactate dehydrogenase elevating virus ORF1ab polyprotein | Q83017 | 1-3616 | peptide-Gly1286+Gly-peptide | P | CS | Phe | Val | Ser | Gly | Gly | His | Val | Ala | Ziebuhr et al., 2000 | ||
| polyubiquitin | P0CG47 | 1-76 | peptide-Gly+Lys48-peptide | N | Leu | Arg | Gly | Gly | Lys | Gln | Leu | Glu | Sun et al., 2010 | |||
| polyubiquitinated NF-kappa-B inhibitor alpha | P0CG47/P25963 | 1-76 | peptide-Gly+Lys-peptide | P | Leu | Arg | Gly | Gly | Lys | Xaa | Xaa | Xaa | Sun et al., 2010 | |||
| Replicase polyprotein 1ab | P19811 | 1-3175 | peptide-Gly831+Gly-peptide | P | Arg | Leu | Ile | Gly | Gly | Trp | Ile | Tyr | Gorbalenya et al., 2004 | 16333 |
